Michael Scolaro

Michael Scolaro

Dec 23, 2017

Group 6 Copy 700
3
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Are current antibacterial treatments resulting in the evolution of more virulent multidrug resistant bacteria?

Each year in the U.S. 23,000 people die as a direct result of antibiotic resistant infections. I hypothesize...

Rapid Detection of Tuberculosis -SCSU-New Haven iGEM

The World Health Organization reports 9.6 million new Tuberculosis cases in 2014. As a global health issue...

Help us pioneer stem cell therapy for giraffe!

Arthritis is common in geriatric giraffe. Cheyenne Mountain Zoo is uniquely suited to help find better arthritis...

Backer Badge Funded